+20 years experience in R&D projects aimed at developing new therapies for CNS indications; +10 years experience in drug repositioning projects aimed at developing products for orphan indications;Seeking out and identifying new business opportunities (scouting activities to identify valuable assets for in-licensing / merger deals; organising and leading various due diligence processes up to the presentation of selected assets to the Company board; business negotiation); Interpreting complex information, data, news and research quickly; building a view on the unmet need and competitive environment in relevant therapeutic areas; identifying the risks associated to potential weaknesses of external assets;Communication of the product value of proprietary products to potential partners for out-licensing / partnership deals purposes, and at international venues;Intimately involved in the writing up of regulatory and scientific documentation; Managing all the preclinical pharmacology /mechanism of action studies of proprietary and external product; selecting and establishing collaboration networks with international experts, CROs, and liaising with Key Opinion Leaders;Line management, leadership of coordinated multidisciplinary project teams working in the research for CNS therapies;Strong scientific background in neurobiology, CNS pharmacology, electrophysiology, animal models;Educational background in Project Management, Regulatory Affairs, Market Access